Misplaced Pages

Daria Mochly-Rosen is a Professor of Chemical and Systems Biology at the Stanford University School of Medicine, where she also holds the George D. Smith Chair for Translational Medicine. She is in addition the founder of Mitoconix Bio, a startup company whose goal is to produce drugs that treat Huntington's disease and other neurodegenerative illnesses.

References

1. "Daria Mochly-Rosen". Stanford University. Retrieved 2018-08-12.
2. "Neurological therapy co Mitoconix Bio raises $20m". Globes. Retrieved 2017-06-27.
3. "California Life Sciences Association (CLSA) Adds Leaders from City of Hope, Stanford to Board of Directors". Retrieved 2017-02-13.
4. Danney, Micah (2017-07-05). "Israeli startup takes aim at Huntington's disease". The Times of Israel. Retrieved 2018-08-12.

External links

• Daria Mochly-Rosen publications indexed by Google Scholar

This article about a biologist is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• American women biologists
• Living people
• Stanford University School of Medicine faculty
• 21st-century American women
• Biologist stubs